N-Acetyl Amphotericin B (CAS 902457-23-2)

N-Acetyl Amphotericin B, a derivative of the antifungal agent amphotericin B, has garnered attention in scientific research for its potential applications in understanding the structure-activity relationships of amphotericin B and exploring novel antifungal strategies. This compound is synthesized through the acetylation of amphotericin B, resulting in modifications to its chemical structure while preserving its antifungal properties. Research has focused on elucidating the mechanisms of action of N-Acetyl Amphotericin B, which are believed to be similar to those of amphotericin B. Specifically, both compounds are thought to exert their antifungal effects by binding to ergosterol, a key component of fungal cell membranes, and forming pores that disrupt membrane integrity, leading to leakage of cellular contents and ultimately fungal cell death. Furthermore, studies have investigated the efficacy of N-Acetyl Amphotericin B against various fungal pathogens, including multidrug-resistant strains, highlighting its potential as a lead compound for the development of novel antifungal agents. Additionally, N-Acetyl Amphotericin B has served as a valuable tool in structure-activity relationship studies, aiding in the design and optimization of more potent and less toxic antifungal compounds. Overall, N-Acetyl Amphotericin B represents a promising avenue for further exploration in antifungal drug discovery and as a tool for investigating fungal membrane biology.